TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 SEK)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
1,264
|
780
|
483 |
| Financial expenses |
444
|
426
|
4 |
| Earnings before taxes |
98
|
69
|
-90 |
| EBITDA |
542
|
484
|
-110 |
| Total assets |
15,047
|
15,144
|
15,273 |
| Current assets |
1,163
|
935
|
698 |
| Current liabilities |
390
|
271
|
165 |
| Equity capital |
14,547
|
14,754
|
14,974 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
96.7%
|
97.4%
|
98.0% |
| Turnover per employee |
1,264
|
780
|
483 |
| Profit as a percentage of turnover |
7.8%
|
8.8%
|
-18.6% |
| Return on assets (ROA) |
3.6%
|
3.3%
|
-0.6% |
| Current ratio |
298.2%
|
345.0%
|
423.0% |
| Return on equity (ROE) |
0.7%
|
0.5%
|
-0.6% |
| Change turnover |
484
|
297
|
-120 |
| Change turnover % |
62%
|
61%
|
-20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.